The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
The ACCEL All-Purpose and Biliary Drainage Catheters are designed for optimal patient comfort and clinical care. The catheter features large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating helps with a smooth catheter insertion.
radeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel ™ 8-Fr aortic transcatheter heart valve (THV) at the New York Valves conference.
“We designed the IntelAir™ to fulfill a market need; while some devices focused on patient needs and others on clinician needs, none appropriately served both. With this all-in-one device, users can benefit from the streamlined approach paired with AMT’s commitment to excellence,” reflected Dr. George Picha M.D., Ph.D., F.A.C.S., Founder & CEO of Applied Medical Technology, Inc.
Frank Baylis, Executive Chairman of Baylis Medical Technologies, expressed enthusiasm about the PowerWire® Pro RF Guidewire’s potential impact, stating, “This innovation aims to simplify the often challenging and time-consuming process of crossing chronic occlusions in revascularization procedures, ensuring uninterrupted patient treatment.”
The Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker’s SOMA database, which includes over 37,000 3D bone models generated from CT scans. The system received CE certification in November 2023 and has been utilized in over 25,000 cases in North America and Japan.
The Tandem Mobi Insulin pump is small enough to be worn almost anywhere, including a coin pocket, providing users with more discretion, comfort, and options for how they manage their diabetes. Powered by Control-IQ technology, which has demonstrated in real-world studies improved time in range overnight and during the day4, Tandem Mobi connects with Dexcom G7 or Dexcom G6 to predict glucose levels 30 minutes in advance and automatically adjusts insulin, if needed, to help prevent highs and lows.